Gary Cutter
Research Areas
Senior Research Scientist
Gary Cutter is a Senior Research Scientist at IHMC and emeritus professor of biostatistics at the University of Alabama at Birmingham School of Public Health. His major interest is in design, analysis and interpretation of clinical trials, epidemiologic studies and evaluation research. His research interests and contributions to science have included clinical trials and epidemiological and clinical studies on multiple sclerosis; myasthenia gravis, cardiovascular research and the benefits of treatment of hypertension; and maternal and fetal medicine research and Alzheimer’s studies.
He served as Associate Director of the NIH National Rehabilitation Research Resource to Enhance Clinical Trials (REACT), Director of the Collaborative Opportunities Core, lead biostatistician for the Pilot Studies Core, clinical trials workshop leader, and Co-leader of the national NIH MR3 Network (funded by NCMRR) Coordinating Center. He is an investigator in the 3-site UAB Clinical Center for the NIH Common Fund Molecular Transducers of Physical Activity Consortium (MoTrPAC) and Co-Chair of the MoTrPAC Data Quality, Data Analysis, and Data Review Committee.
Gary has directed numerous national and multinational coordinating centers, patient registries and epidemiological studies. He advises nationally on the design of many studies and has been director of the Biostatistics Basic Research of the UAB/USCD O’Brien Center focused on acute kidney disease. He was a member of the Clinical Advisory Panel for NINDS offering recommendations on how to improve clinical research at NINDS, and currently serves on the Protocol Review Committee for the Bone Marrow Transplant Program at NHLBI.
He serves on numerous data and safety monitoring committees for NIH and Industry, and he serves on the editorial boards of the Multiple Sclerosis Journal, Multiple Sclerosis and Related Diseases, Alzheimer’s and Dementia, and the statistical editor for the Journal of the American Society of Nephrology and recently finished his tenure as contributing editor to Neurology: Clinical Practice, while also reviewing for major journals in numerous areas. He is a past president of the Consortium of MS Centers and remains on their board.
He has a long history of multi-institutional, collaborative research and leadership in coordinating centers and multicenter trials where diverse disciplines must seamlessly work together. He earned a bachelor’s degree in mathematics from the University of Missouri Columbia. His master’s and Ph.D. in biometry both come from the University of Texas School of Public Health. He has published more than 765 papers and his contributions span multiple diseases with significant contributions to hypertension, neonatal research, pregnancy outcomes and most notably multiple sclerosis and myasthenia gravis.